DAWN earnings: a positive outcome, +16.7%

On May 1, 2023, Day One Biopharmaceuticals, Inc. reached its earnings. The result was a positive outcome, and the stock moved +16.7% in the window around the event. It had already run -7.3% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.